Short report: high prevalence and imbalanced age distribution of the Plasmodium falciparum dihydrofolate reductase gene Asn108 mutation in an area of low pyrimethamine usage in Nigeria.

F P Mockenhaupt Institute for Tropical Medicine, Medical Faculty Charité, Humboldt-University Berlin, Germany.

Search for other papers by F P Mockenhaupt in
Current site
Google Scholar
PubMed
Close
,
J May Institute for Tropical Medicine, Medical Faculty Charité, Humboldt-University Berlin, Germany.

Search for other papers by J May in
Current site
Google Scholar
PubMed
Close
,
T A Eggelte Institute for Tropical Medicine, Medical Faculty Charité, Humboldt-University Berlin, Germany.

Search for other papers by T A Eggelte in
Current site
Google Scholar
PubMed
Close
,
F L Thies Institute for Tropical Medicine, Medical Faculty Charité, Humboldt-University Berlin, Germany.

Search for other papers by F L Thies in
Current site
Google Scholar
PubMed
Close
,
O G Ademowo Institute for Tropical Medicine, Medical Faculty Charité, Humboldt-University Berlin, Germany.

Search for other papers by O G Ademowo in
Current site
Google Scholar
PubMed
Close
,
U Bienzle Institute for Tropical Medicine, Medical Faculty Charité, Humboldt-University Berlin, Germany.

Search for other papers by U Bienzle in
Current site
Google Scholar
PubMed
Close
, and
C G Meyer Institute for Tropical Medicine, Medical Faculty Charité, Humboldt-University Berlin, Germany.

Search for other papers by C G Meyer in
Current site
Google Scholar
PubMed
Close
Restricted access

Resistance of Plasmodium falciparum to pyrimethamine is associated with a non-silent point mutation of the parasite dihydrofolate reductase (DHFR) gene (Ser108 --> Asn108). Wide-scale use of antimalarials is thought to contribute to the emergence of drug resistance. In 131 P. falciparum-infected children in rural Nigeria, the frequency of the resistant Asn108 genotype was assessed by enzymatic restriction digestion of polymerase chain reaction-amplified DHFR sequences and compared with residual pyrimethamine blood levels. The prevalence of the Asn108 variant was 41.2%. In 18.3% of the isolates, both the Asn108 and the wild-type alleles were present. In contrast to the high prevalence of resistant genotypes, residual pyrimethamine blood levels were detected in only 4%. Furthermore, age was found to be a determinant of the parasite genotype since the proportion of Asn108 variants decreased with age (P < 0.05). These findings indicate that additional, unidentified factors, rather than selection by residual drug levels alone, might be responsible for the emergence of pyrimethamine-resistant parasite genotypes.

Author Notes

Save